62
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores

, , , , , , & show all
Pages 471-476 | Published online: 21 Nov 2016

References

  • AntmanEMCohenMBerninkPJThe TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision makingJAMA2000284783584210938172
  • GrangerCBGoldbergRJDabbousOGlobal Registry of Acute Coronary Events InvestigatorsPredictors of hospital mortality in the Global Registry of Acute Coronary EventsArch Intern Med2003163192345235314581255
  • FoxKADabbousOHGoldbergRJPrediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)BMJ20063337578109117032691
  • RoffiMPatronoCColletJ-P2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEur Heart J201637267315 Available from: http://www.escardio.org/guidelinesAccessed September 11, 201526320110
  • AragamKGTamhaneUUKline-RogersEDoes simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scoresPLoS One2009411e794719956773
  • de Araújo GonçalvesPFerreiraJAguiarCSeabra-GomesRTIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACSEur Heart J200526986587215764619
  • MuellerCBiomarkers and acute coronary syndromes: an updateEur Heart J201435955255624357507
  • ThygesenKMairJMuellerCRecommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the study group on biomarkers in cardiology of the ESC working group on acute cardiac careEur Heart J201233162001200621292681
  • Garcia-AlvarezARegueiroAHernándezJKasaGSitgesMBoschXHerasMAdditional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndromeEur Heart J Acute Cardiovasc Care20143213214024448752
  • GuidezTMarechauxSPinconCAddition of B-type natriuretic peptide to the GRACE score to predict outcome in acute coronary syndrome: a retrospective (development) and prospective (validation) cohort-based studyEmerg Med J201229427427921521903
  • WideraCPencinaMJMeisnerAAdjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndromeEur Heart J20123391095110422199121
  • MeuneCDrexlerBHaafPThe GRACE score’s performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptideHeart201197181479148321444339
  • AngDSWeiLKaoMPLangCCStruthersADA comparison between B-type natriuretic peptide, Global Registry of Acute Coronary Events (GRACE) score and their combination in ACS risk stratificationHeart201096322722820133421
  • ReesukumalKPratumvinitBB-type natriuretic peptide not TIMI risk score predicts death after acute coronary syndromeClin Lab2012589–101017102223163118
  • KimJHJeongMHAhnYOther Korea acute Myocardial Infarction Registry (KAMIR) InvestigatorsA novel risk stratification model for patients with non-ST elevation myocardial infarction in the Korea acute myocardial infarction registry (KAMIR): limitation of the TIMI risk scoring systemChonnam Med J2011471202622111052
  • Tello-MontoliuAMarinFRoldánVA multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT-proBNP and fibrin D-dimerJ Intern Med2007262665165817986200
  • de LemosJAMorrowDABentleyJHThe prognostic value of B-type natriuretic peptide in patients with acute coronary syndromesN Eng J Med20013451410141021
  • JernbergTStridsbergMVengePLinahlBN-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chestpain and no ST-segment elevationJ Am Coll Cardiol200240343744512142108
  • KwanGIsaksonSRBeedeJCloptonPMaisalASFitzgeraldRLShort-term serial sampling of natriuretic peptides in patients presenting with chest painJ Am Coll Cardiol200749111186119217367663
  • PesaroAEPKatzMCaixetaAPrognostic value of serial brain natriuretic peptide measurements in patients with acute myocardial infarctionCardiology2015131211612125895555
  • EzekowitzJAThérouxPChangWN-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionCan J Cardiol200622539339716639474
  • EzekowitzJAThérouxPWelshRBataIWebbJArmstrongPWInsights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?Can J Physiol Pharmacol200785117317817487257
  • BriegerDFoxKAFitzgeraldGGlobal Registry of Acute Coronary Events investigatorsPredicting freedom from clinical events in non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary EventsHeart2009951188889419246481
  • SchellingsDAAdiyamanAGiannitsisEEarly discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk ScoreJ Am Heart Assoc201436e00108925389283